Crossmark

The IκB-protein BCL-3 controls Toll-like receptor-induced MAPK activity by promoting TPL-2 degradation in the nucleus

Crossref DOI link: https://doi.org/10.1073/pnas.1900408116

Published Online: 2019-11-26

Published Print: 2019-12-17

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Collins, Patricia E.

Somma, Domenico

Kerrigan, David

Herrington, Felicity

Keeshan, Karen

Nibbs, Robert J. B.

Carmody, Ruaidhrí J. https://orcid.org/0000-0002-9474-4507
Funding

Funding for this research was provided by:

RCUK | Biotechnology and Biological Sciences Research Council (BB/M003671/1)

RCUK | Medical Research Council (MR/M010694/1)
License Information

Version of Record valid from 2019-11-26
More Information

Publication History

Published: 2019-11-26